Welcure Drugs & Pharmaceuticals Ltd Quarterly Result
Welcure Drugs & Pharmaceuticals Ltd
NSE: WELCUREDRUGS
Net Profit - Last Quarter
Welcure Drugs & Pharmaceuticals Ltd Quarterly Results Key Highlights
- The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.46 crore.
- This represent the decline of -100% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ -49.86 crore as compare to the Dec '25 ebitda of ₹ 1.43 crore.
- This represent the decline of -3586% The net profit of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ -49.86 crore as compare to the Dec '25 net profit of ₹ 1.07 crore.
- This represent the decline of -4759%.
Welcure Drugs & Pharmaceuticals Ltd Quarterly Results Analysis
Market Price of Welcure Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 12 Jun 2026 | 0.27 |
| 11 Jun 2026 | 0.25 |
| 10 Jun 2026 | 0.26 |
| 09 Jun 2026 | 0.27 |
| 08 Jun 2026 | 0.26 |
| 05 Jun 2026 | 0.26 |
| 04 Jun 2026 | 0.26 |
| 03 Jun 2026 | 0.26 |
| 02 Jun 2026 | 0.27 |
| 01 Jun 2026 | 0.28 |
Historical Revenue of Welcure Drugs & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Welcure Drugs & Pharmaceuticals Ltd
Historical EBITDA of Welcure Drugs & Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Welcure Drugs & Pharmaceuticals Ltd
Historical Net Profit of Welcure Drugs & Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Welcure Drugs & Pharmaceuticals Ltd
Welcure Drugs & Pharmaceuticals Ltd News Hub
Welcure Drugs & Pharmaceuticals reports standalone net loss of Rs 0.35 crore in the June 2024 quarter
Net Loss of Welcure Drugs & Pharmaceuticals reported to Rs 0.35 crore in the quarter ended June 2024
Read more
14 Aug 24
Welcure Drugs & Pharmaceuticals to table results
Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 A
Read more
09 Aug 24
Welcure Drugs & Pharmaceuticals to hold board meeting
Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 Se
Read more
30 Aug 24
Welcure Drugs & Pharmaceuticals to conduct AGM
Welcure Drugs & Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will
Read more
11 Sept 24
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Welcure Drugs & Pharmaceuticals Ltd
- Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
- The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
- The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
- It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.
FAQs for Quarterly Results of Welcure Drugs & Pharmaceuticals Ltd
What key financial metrics are included in Welcure Drugs & Pharmaceuticals Ltd's quarterly results?
When does Welcure Drugs & Pharmaceuticals Ltd announce its quarterly results?
How does Welcure Drugs & Pharmaceuticals Ltd's quarterly performance impact its stock price?
What is the impact of Welcure Drugs & Pharmaceuticals Ltd's quarterly results on dividends?
Are there any special announcements usually made during Welcure Drugs & Pharmaceuticals Ltd's quarterly results?
